baber/WOPTO huggingface dataset:
Patent MX-2017012526-A (MX)
Title: Fail functional automated driving.
Inventor: ERIC SHE
IPC: G08B29/16
Filed: 2017-09-28
Abstract: A vehicle system includes a first communication path and a second communication path. The vehicle system further includes a processor programmed to determine a first communication speed associated with communicating over the first communication path and a secondary communication speed associated with communicating over the second communication path. The processor commands a first vehicle subsystem to communicate over the first communication path or the second communication path based at least in part on the first communication speed and the secondary communication speed.
Patent MX-2017012966-A (MX)
Title: Interleukin-2 muteins for the expansion of t-regulatory cells.
Inventor: GUNASEKARAN KANNAN
IPC: C07K14/55
Filed: 2016-05-04
Abstract: Provided herein are IL-2 muteins, IL-2 mutein Fc-fusion molecules, anti-IL-2 antibodies, and complexes comprising an anti IL-2 antibody bound to an IL-2 cytokine that preferentially expand and activate T regulatory cells and are amenable to large scale production. Also provided herein are variant human IgG1 Fc molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also provided herein are linker peptides that are glycosylated when expressed in mammalian cells. Also provided herein are methods of making and using the compositions of the present invention.
Patent MX-2017013814-A (MX)
Title: Electrically conductive material composition.
Inventor: JURGEN BUHRING
IPC: C09D7/43
Filed: 2016-01-21
Abstract: The invention relates to a composition comprising at least a matrix polymer, electrically conductive particles and at least one organic liquid salt, wherein the weight ratio between the at least one matrix polymer and the electrically conductive particles is between 4:1 and 1:5; and the weight ratio between matrix polymer and organic liquid salt is between 1000:1 and 1:1; and the sum of the weights of matrix polymer, electrically conductive particles and organic liquid salt is at least 65 % based on the total weight of the composition. The invention further relates to the production and use of such a composition.
Patent MX-2017014815-A (MX)
Title: Apparatus and method for detecting improper positioning of removable component of sterilizing system.
Inventor: DOUG VO TRUONG
IPC: A61L2/24
Filed: 2017-11-17
Abstract: A sterilization system includes a sterilization chamber, a processor, and a sterilization module. The sterilization module includes a frame assembly, an extraction assembly, and a carriage assembly. The extraction assembly is configured to extract a sterilant fluid from a cartridge and transfer the sterilant fluid to the sterilization chamber. The carriage assembly includes a motor, a carriage body, and a translating flag. The carriage body is configured to receive the cartridge. The translating flag is configured to move from a first position to a second position relative to the carriage body in response to the carriage body receiving the cartridge. The sensor is configured to detect movement of the translating flag from the first position to the second position.
Patent MX-2017017094-A (MX)
Title: An aerosol-generating device, system and method with a heated gas sensor.
Inventor: JÉRÔME COURBAT
IPC: A24F40/53
Filed: 2016-06-29
Abstract: An aerosol-generating device configured to heat an aerosol-forming substrate, comprising: a power supply, a heater positioned to heat the aerosol-forming substrate to form an aerosol, a controller configured to control the supply of power from the power supply to the heater and a gas sensor, wherein a response of the gas sensor is dependent on a temperature of the gas sensor, and wherein the controller is connected to the gas sensor and is configured to monitor signals from the gas sensor. When the heater is mounted on a supporting substrate, the gas sensor may advantageously be mounted on the supporting substrate, proximate to the heater.
Patent MX-2018000262-A (MX)
Title: Therapeutic uses of berberine formulations.
Inventor: LIN I-YIN
IPC: A61P31/10
Filed: 2016-06-24
Abstract: Uses of pharmaceutical compositions comprising berberine for treatment of dermatologic toxicities and other skin disorders.
Patent MX-2018001337-A (MX)
Title: Flow meter having electronic mount bracket assembly.
Inventor: RANDEEP SINGH GREWAL
IPC: G01F15/18
Filed: 2016-07-27
Abstract: A flow meter includes a meter body having a longitudinal axis and including a fluid passageway and an outer surface, and a plurality of electronics housings supported on the meter body by a mounting member, wherein the mounting member includes a base, a tubular member having a passage extending therethrough for the passing of a transducer cable, and a bracket member coupled to the tubular member distal the base, the bracket member having a pair of elongate slots, each configured to allow for the passage of a transducer cable to one of the electronics housings.
Patent MX-2018005216-A (MX)
Title: Convertible top incorporating a heat generating element.
Inventor: MICHAEL JAMES WHITENS
IPC: H05B3/84
Filed: 2018-04-26
Abstract: A convertible top includes an outer layer, a liner and a heating element between the outer layer and the liner. The heating element may comprise a carbon nanotube heating element. A controller is configured to activate the heating element in response to a wireless activation signal received from a remote communication device.
Patent MX-2018008219-A (MX)
Title: Spiroheptane salicylamides and related compounds as inhibitors of rock.
Inventor: WU YANG
IPC: C07D231/12
Filed: 2017-01-13
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
Patent MX-2018012245-A (MX)
Title: Modular and expandable fire suppression system.
Inventor: BRIAN LEE COUNTS
IPC: G08B25/04
Filed: 2017-04-06
Abstract: A tire suppression system includes a centralized controller and a plurality of modules (14). Each module includes a housing (30), a printed circuit board (32) with a mounted microprocessor (34), a first connector (36) including a first pair of data wires (38) mounted to the board; and a second connector (40) including a second pair of data wires (42) mounted to the board so that the printed circuit board electrically connects the first and second pairs of data wires. The modules are interconnected with the central controller to define data buses for centralized fire detection, user interface and system response. The connectors of each module interconnect the plurality of modules in series to the central controller.
Patent MX-2018012868-A (MX)
Title: Compositions and methods for making antibodies based on use of expression-enhancing loci.
Inventor: GANG CHEN
IPC: C07K16/46
Filed: 2017-04-20
Abstract: This invention relates to site-specific integration and expression of recombinant proteins in eukaryotic cells. In particular, the invention includes compositions and methods for improved expression of antigen-binding proteins including monospecific and bispecifc antibodies in eukaryotic cells, particularly Chinese hamster (Cricetulus griseus) cell lines, by employing multiple expression-enhancing locus.
Patent MX-2019001493-A (MX)
Title: RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION.
Inventor: DARREN H WAKEFIELD
IPC: C07H21/02
Filed: 2017-08-04
Abstract: Described are compositions and methods for inhibition of Hepatitis B virus gene expression. RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B virus gene are described. The HBV RNAi agents disclosed herein may be targeted to cells, such as hepatocytes, for example, by using conjugated targeting ligands. Pharmaceutical compositions comprising one or more HBV RNAi agents optionally with one or more additional therapeutics are also described. Delivery of the described HBV RNAi agents to infected liver in vivo provides for inhibition of HBV gene expression and treatment of diseases and conditions associated with HBV infection.
Patent MX-2019004321-A (MX)
Title: Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase.
Inventor: ROBERTO PELLICCIARI
IPC: C07D233/40
Filed: 2017-10-13
Abstract: The present disclosure discloses compounds capable of modulating the activity of a- amino-ß-carboxymuconic acid semialdehyde decarboxylase (ACMSD), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in NAD+ biosynthesis, e.g., metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application also discloses pharmaceutical compositions comprising said compounds and the use of such compounds as a medicament.
Patent MX-2019004960-A (MX)
Title: Use of 1-[(4r)-4-methylcyclohexen-1-yl]ethanone as an aroma chemical.
Inventor: RALF PELZER
IPC: A61K8/35
Filed: 2017-10-25
Abstract: Use of 1-[(4R)-4-methylcyclohexen-1-yl]ethanone to impart a ylang-ylang note to a composition.
Patent MX-2019005533-A (MX)
Title: Treatment for fibrosis.
Inventor: TALI GORFINE
IPC: A61K45/06
Filed: 2017-11-10
Abstract: The invention relates to the treatment and reduction of fibrosis, including hepatic fibrosis. More specifically, embodiments of the invention provide compositions and methods useful for the treatment and inhibition of fibrotic disorders, hepato-fibrotic conditions associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), employing the use of 33-arachidylamido-7a, 12a-dihydroxy-5ß-cholan-24-oic acid (Aramchol) or a pharmaceutically acceptable salt thereof. In other embodiments, the treatment and inhibition of hepato-fibrotic conditions caused by contact with hepatotoxic chemical substances or by mechanical obstruction is contemplated.
Patent MX-2019006725-A (MX)
Title: Adenovirus polynucleotides and polypeptides.
Inventor: STEFANO COLLOCA
IPC: C12N15/861
Filed: 2017-12-07
Abstract: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
Patent MX-2019007122-A (MX)
Title: Mobile utility articulating boom system.
Inventor: JOEL FERLAND
IPC: B66C23/00
Filed: 2017-12-14
Abstract: A boom system for transporting and deployment of utility service lines (such as cables, wires, hoses, pipes, etc.) from sources of the services to a drilling rig. The mobile boom system includes a mobile skid with posts located at opposite ends of the skid, and one or more articulating booms pivotally attached to each skid post. One or more articulating booms attached to a post at the first end of the skid can support and carry the service lines connected to the sources and one or more articulating booms attached to a post at the second end of the skid can support and carry the service lines connected to a drilling rig, or to an articulating boom extending from a drilling rig. The mobile articulating boom system can include means for moving and selectively positioning the mobile articulating boom system at a drilling site.
Patent MX-2019008949-A (MX)
Title: Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure.
Inventor: KATSUTO TAMAI
IPC: A61K38/17
Filed: 2018-01-26
Abstract: The present inventors have found that an HMGB1 fragment peptide having a specific amino acid sequence exhibits an effect to improve the function of the heart, prevent cardiomyocyte hypertrophy, prevent myocardial fibrosis and promote angiogenesis in an animal model with dilated cardiomyopathy, the specific HMGB1 fragment peptide also exhibits an effect to improve the function of the heart, prevent auxocardia, prevent cardiomyocyte hypertrophy, prevent myocardial fibrosis and promote angiogenesis in an animal model with ischemic cardiomyopathy associated with old myocardial infarction, and the specific HMGB1 fragment peptide exhibits an effect to prevent cardiomyocyte hypertrophy and prevent myocardial fibrosis in an animal model with hypertensive cardiomyopathy. On the basis of this finding, a pharmaceutical composition for preventing and/or treating cardiomyopathy, old myocardial infarction, and chronic heart failure associated with these diseases is provided, which contains an HMGB1 fragment peptide having a specific amino acid sequence.
Patent MX-2019009788-A (MX)
Title: Substituted imidazo-quinolines as nlrp3 modulators.
Inventor: SHOMIR GHOSH
IPC: A61K31/437
Filed: 2018-02-16
Abstract: This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that modulate (e.g., agonizes or partially agonizes) NLRP3 that are useful, e.g., for treating a condition, disease or disorder in which an increase in NLRP3 signaling may correct a deficiency in innate immune activity (e.g., a condition, disease or disorder associated with an insufficient immune response) that contributes to the pathology and/or symptoms and/ or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions as well as other methods of using and making the same.
Patent MX-2019010077-A (MX)
Title: Apparatus for filling vehicles on assembly lines in the automobile industry.
Inventor: BERND PREISSLER
IPC: B60H1/00
Filed: 2018-03-22
Abstract: The invention relates to an apparatus for filling vehicles on automobile industry assembly lines on which vehicles are filled with a number of different operating media that are each fed into the vehicle circuits and containers from filling stations via connecting lines and specific adapters. The aim of the invention is to create a technical solution that allows the operating media to be filled in less time and with less handling effort than with prior art variants. Said aim is achieved in that the connections to all containers and circuits in a vehicle (2) that are to be filled with an operating medium are structurally integrated into a common subassembly which is in the form of a filling box (1), is installed in the vehicle (2) and can be brought into operative connection with a filling tool (7) on which the connections to all filling stations for the different operating media are structurally integrated; furthermore, the connections on the filling box (1) in the vehicle (2) and the connections on the filling tool (7) that are allocated to the same operating medium and are to be brought into operative connection with one another have congruent contours.
Patent MX-2019011808-A (MX)
Title: Engineered gram-negative endolysins.
Inventor: MANFRED BIEBL
IPC: C12N15/11
Filed: 2018-04-02
Abstract: The present invention relates in general to the field of antimicrobial enzymes. In particular, the present invention relates to a polypeptide comprising the amino acid sequence of a globular Gram-negative endolysin and the amino acid sequence of a cell wall binding domain of i) a modular Gram-negative endolysin or ii) a bacteriophage tail/baseplate protein. The present invention relates also to corresponding nucleic acids, vectors, bacteriophages, host cells, and compositions. The present inventions also relates to the use of said polypeptides, nucleic acids, vectors, bacteriophages, host cells, and compositions in methods for treatment of the human or animal body by surgery or therapy or in diagnostic methods practiced on the human or animal body. The polypeptides, nucleic acids, vectors, bacteriophages, host cells, and compositions according to the invention may also be used as an antimicrobial in, e.g., food or feed, in cosmetics, or as disinfecting agent.
Patent MX-2019013229-A (MX)
Title: Systems and methods for visualizing clinical trial site performance.
Inventor: MORALES ARTURO J
IPC: A61B5/103
Filed: 2018-05-09
Abstract: Systems and methods for visualizing clinical trial site performance, or other multi-dimensional (or multi-parameter) datasets.
Patent MX-2019014456-A (MX)
Title: Transmitting apparatus and interleaving method thereof.
Inventor: KYUNG-JOONG KIM
IPC: H03M13/11
Filed: 2016-11-18
Abstract: A transmitting apparatus is provided. The transmitting apparatus includes: an encoder configured to perform a low-density parity check (LDPC) encoding on input bits using a parity check matrix to generate an LDPC codeword comprising information word bits and parity bits; an interleaver configured to interleave the LDPC codeword; and a modulator configured to map the interleaved LDPC codeword onto a modulation symbol, wherein the modulator is further configured to map a bit included in a predetermined bit group from among a plurality of bit groups constituting the LDPC codeword onto a predetermined bit of the modulation symbol.
Patent MX-2020002700-A (MX)
Title: Lightning protection system for a wind turbine and wind turbine comprising such a lightning protection system.
Inventor: GARCÍA PÉREZ JOSÉ MANUEL
IPC: F03D9/25
Filed: 2020-03-10
Abstract: Provided is a lightning protection system for a wind turbine, including a connection unit to be placed between a nacelle and at least one blade of the wind turbine for conducting lightning current and/or static energy from the at least one blade to the nacelle, the connection unit including a first end portion with at least one nacelle contacting element, a second end portion with at least one blade contacting element, at least one first support member supporting the at least one nacelle contacting element, at least one second support member supporting the at least one blade contacting element, a base portion located between the first support member and the second support member, and at least one shifting element mechanically connecting the first support member and/or the second support member slidably relative to the base portion for amending a length of the connection unit in an amending direction from the blade to the nacelle.
Patent MX-2020002850-A (MX)
Title: Methods of reducing particle formation and compositions formed thereby.
Inventor: PATEL MAYANK
IPC: A61K47/26
Filed: 2018-08-10
Abstract: Biopharmaceutical compositions and drug products disclosed herein exhibit reduced amounts of subvisible particle formation. Compositions and drug products disclosed herein comprise a protein and a surfactant or stabilizer including high percentage amounts (e.g., at least 97%) of a long-chain fatty acid ester. Also disclosed herein are methods of preparing and storing such compositions and drug products.
Patent MX-2020004276-A (MX)
Title: Spinning position, air spinning machine and method for producing a yarn.
Inventor: SESHAYER CHANDRASSEKARAN
IPC: D01H13/00
Filed: 2020-07-13
Abstract: A spinning position for producing a yarn from a fed fiber band, having an air spinning nozzle with an inlet opening for the fed fiber band and an outlet area with an outlet opening for the spun yarn is provided. In order to provide a spinning position, an air spinning machine and a method which allow for the yarn surface finish to be modified advantageously without the yarn properties deteriorating at the same time, while also avoiding expensive and complex modifications to the spinning position, there is provision for a navel to be arranged in the outlet area behind the outlet opening for modifying the surface finish of the spun yarn.
Patent MX-2020006410-A (MX)
Title: Air-dryer-purge-type air cleaner device comprising structured absorbent particles.
Inventor: HOWE STEPHEN
IPC: B60T17/00
Filed: 2018-12-13
Abstract: An absorbent apparatus is provided for an air dryer purge air cleaner. The absorbent apparatus comprises a volume for containing absorbent material. The absorbent apparatus also comprises absorbent material that is both oleophilic and hydrophobic and is packed in the volume to provide a packed bed of absorbent material with a predetermined packing density.
Patent MX-2020010731-A (MX)
Title: Mammalian mhc peptide display as an epitope selection tool for vaccine design.
Inventor: KISIELOW JAN
IPC: G01N33/68
Filed: 2019-04-12
Abstract: The present invention relates to a method for identifying candidate peptides presented by major histocompatibility complex (MHC) for vaccination, induction of immunological tolerance, blocking of TCRs, MHC-mediated toxin delivery and redirecting T cells with CARs, for immunogenicity testing and other in vitro T-cell reactivity tests. The invention further relates to a method for determining the MHC binding affinity of candidate peptides.
Patent MX-2020014114-A (MX)
Title: Merge mode-based inter-prediction method and apparatus.
Inventor: KIM KI BAEK
IPC: H04N19/70
Filed: 2019-07-01
Abstract: The present invention relates to a video encoding/decoding method and apparatus, comprising the steps of: establishing a merge candidate list of a current block; deriving motion information of the current block from the merge candidate list; and carrying out inter-prediction on the current block by using the motion information, wherein the merge candidate list includes at least one among a spatial merge candidate, a temporal merge candidate, and a combined merge candidate, and the combined merge candidate is derived by combining a number n of merge candidates which belong to the merge candidate list. The present invention has the effect of increasing the accuracy of motion information by using a combined merge candidate as well as a spatial/temporal merge candidate.
Patent MX-2021001499-A (MX)
Title: Isocyanate-group-containing polymer having a low content of monomeric diisocyanates.
Inventor: SCHLUMPF MICHAEL
IPC: C09D175/08
Filed: 2019-08-05
Abstract: The invention relates to an isocyanate group-containing polyether urethane polymer having an NCO content in the range from 1.3 to 1.9 wt% and a content of monomeric diisocyanates of not more than 0.5 wt%, derived from the reaction of at least one monomeric aromatic diisocyanate and a polyether triol having an average OH functionality in the range from 2.2 to 2.6, an OH number in the range from 25 to 32 mg KOH/g in an NCO/OH ratio of at least 3:1 and subsequent removal of a majority of the monomeric diisocyanates by means of a suitable separation process, and moisture-curing polyurethane compositions having a content of monomeric diisocyanates of less than 0.1 wt% containing said polymer. The polymer according to the invention allows very storage-stable moisture-curing polyurethane compositions, which are safe to handle even without special protective measures, are easy to process, have a long open time, cure rapidly to provide an elastic material of high extensibility and elasticity with high strength, high tear propagation resistance, good low-temperature flexibility, good adhesion properties and high resistance, in particular with respect to heat and UV radiation. Such polyurethane compositions are in particular suitable as elastic adhesives, sealants, and coatings.